Meal Timing for Obesity
(CM Trial)
Trial Summary
What is the purpose of this trial?
Preliminary findings from the investigators' lab suggest that circadian misalignment, occurring when meals and sleep are mistimed from one another, alters resting state neuronal processing in areas relevant to food reward and interoception; supporting a role of sleep and meal misalignment, on energy balance regulation. No study has been done to disentangle the effects of sleep and meal timing on body weight regulation, independent of sleep duration. This study will provide information to guide messaging related to timing of meals and sleep that can be translated to individuals whose sleep follows unconventional times, such as shift workers and those with jetlag and social jetlag.
Will I have to stop taking my current medications?
The trial requires that participants do not take certain medications, such as psychoactive or hypnotic medications, chronic pain or anti-inflammatory medications, and beta blockers. If you are taking any of these, you may need to stop before joining the trial.
What data supports the effectiveness of the treatment Meal Timing for Obesity?
Is meal timing safe for humans?
How does meal timing as a treatment for obesity differ from other treatments?
Meal timing as a treatment for obesity is unique because it focuses on the timing of food intake rather than the type or amount of food consumed. This approach aims to align eating patterns with the body's natural circadian rhythms, potentially improving metabolism and aiding weight control, unlike traditional methods that primarily focus on calorie restriction or specific diets.1251011
Research Team
Marie-Pierre St-Onge, PhD
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for adults with obesity (BMI of 25-34.9) who usually sleep at least 7 hours, starting at or before 4 AM, and eat within an hour of waking up. It's open to all races and ethnicities. People can't join if they have sleep disorders, severe insomnia, psychiatric conditions, recent significant weight changes, are pregnant or post-partum within a year, have high alcohol intake or substance abuse history.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Circadian Alignment Phase
Participants consume meals aligned to the sleep episode, from 9 AM to 7 PM
Circadian Misalignment Phase
Participants consume meals misaligned to the sleep episode, from 1 PM to 11 PM
Free-living Period
Participants follow prescribed meal times for each phase in a free-living environment
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Meal times
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
NYU Langone Health
Collaborator